Celiac Center, Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Gastroenterology. 2013 May;144(5):912-917.e1. doi: 10.1053/j.gastro.2013.01.033. Epub 2013 Jan 24.
BACKGROUND & AIMS: We investigated whether risk for non-insulin-dependent diabetes mellitus (NIDDM) and metabolic syndrome are affected by celiac disease. We examined the prevalence of NIDDM and metabolic syndrome among adults with celiac disease, compared with matched controls.
We assessed medical records of 840 patients with biopsy-proven celiac disease for diagnoses of NIDDM, hypertension, or hyperlipidemia; body mass index (BMI); lipid profile; and levels of glucose or glycosylated hemoglobin, to identify those with metabolic syndrome. Patients without celiac disease were matched for age, sex, and ethnicity (n = 840 controls). The prevalence of NIDDM and metabolic syndrome in the celiac disease cohort was compared with that of the controls and subjects included in the National Health and Nutrition Examination Survey.
Twenty-six patients with celiac disease (3.1%) had NIDDM compared with 81 controls (9.6%) (P < .0001). Similarly, the prevalence of metabolic syndrome was significantly lower among patients with celiac disease than controls (3.5% vs 12.7%; P < .0001). The mean BMI of patients with celiac disease was significantly lower than that of controls (24.7 vs 27.5; P < .0001). However, celiac disease was still associated with a lower risk of NIDDM, after controlling for BMI.
The prevalence of NIDDM and metabolic syndrome are lower among patients with celiac disease than in matched controls and the general population. These differences are not explained by differences in BMI. Studies are needed to determine the mechanisms by which celiac disease affects the risk for NIDDM and metabolic syndrome.
我们研究了乳糜泻患者发生非胰岛素依赖型糖尿病(NIDDM)和代谢综合征的风险是否受到影响。我们对比了乳糜泻患者与匹配对照者中 NIDDM 和代谢综合征的流行率。
我们评估了 840 例经活检证实的乳糜泻患者的病历,以确定其是否患有 NIDDM、高血压或高脂血症、体重指数(BMI)、血脂谱、葡萄糖或糖化血红蛋白水平,以识别患有代谢综合征的患者。未患乳糜泻的患者按年龄、性别和种族(n = 840 例对照者)进行匹配。比较乳糜泻患者队列的 NIDDM 和代谢综合征的流行率与对照者和国家健康与营养检查调查(National Health and Nutrition Examination Survey)中包含的受试者。
26 例乳糜泻患者(3.1%)患有 NIDDM,而 81 例对照者(9.6%)患有 NIDDM(P <.0001)。同样,乳糜泻患者代谢综合征的患病率明显低于对照者(3.5% vs 12.7%;P <.0001)。乳糜泻患者的平均 BMI 明显低于对照者(24.7 vs 27.5;P <.0001)。然而,在校正 BMI 后,乳糜泻仍与 NIDDM 风险降低相关。
与匹配对照者和一般人群相比,乳糜泻患者的 NIDDM 和代谢综合征的流行率较低。这些差异不能用 BMI 的差异来解释。需要进行研究以确定乳糜泻影响 NIDDM 和代谢综合征风险的机制。